Floatz logo

Aleta-001

Large B-cell Lymphoma

Cancer Research UKPhase 1/2Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
73/ 100

Competitive context

71 Active assets in the Large B-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Axicabtagene Ciloleucel
Zhejiang Cancer Hospital
Phase 4BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 4BB
Fludarabine
M.D. Anderson Cancer Center
Phase 4BB
ETOPOSIDE
University of California, Davis
Phase 2/3BB
PREDNISONE TABLETS
Ruijin Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

Aleta-001 is also rated in:

mantle cell lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
follicular lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
diffuse large B-cell lymphomaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →